December 9, 2005
Contact: Jennifer Ekman
jekman@usouthal.edu 251.460. 6360

Point Clear Polo Classic Donation -- Representatives of the Point Clear Polo Classic present a $100,000 donation to the University of South Alabama to support the USA Cancer Research Institute at a recent luncheon held to recognize the charitable group. The donation was made possible by proceeds from the 2005 Point Clear Polo Classic held in October. From left: USA Cancer Research Institute Director Dr. Michael Boyd, USA President Gordon Moulton, Polo Classic Co-Chair Camille Corte, Polo Classic Co-Chair Anne Nix, Point Clear Polo Foundation President Bob Edmundson and Point Clear Polo Foundation Trustee Hutch Radcliff.

Representatives from the Point Clear Polo Foundation and the Point Clear Polo Classic Organizing Committee recently made a $100,000 donation to the University of South Alabama to support the USA Cancer Research Institute.

The donation was made possible by proceeds from the 2005 Point Clear Polo Classic. USA’s Cancer Research Institute was the primary beneficiary of the charity event, which was held in October.

Polo Classic event leaders Camille Corte, Anne Nix, Bob Edmundson, and Hutch Radcliff presented the check to USA President Gordon Moulton and USA Cancer Research Institute Director Dr. Michael Boyd.

This is the charitable group’s latest installment in what has been a long history of giving to the University. Point Clear Polo has sponsored USA cancer research for more than a decade, generating approximately $2.5 million in support of an endowed chair in cancer research and other projects, including $200,000 in contributions to Project Hope, a program benefiting pediatric cancer patients at USA Children’s and Women’s Hospital. This most recent donation brings the organization’s total contribution to approximately $3.1 million.

The USA Cancer Research Institute was created to help prevent, treat and cure cancer in the upper Gulf Coast region. It will increase care and treatment options for cancer patients, providing local access to high technology medicine.